A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference product. Biosimilar products are made of complex molecules with high molecular weight produced through genetic engineering in living cells. Biologics drugs are costlier than respective chemical drugs. Biosimilar drugs can save around 30 to 40 % in terms of price relative to the respective biologics drugs. Biosimilars are useful for the treatment of illnesses such as anemia, autoimmune diseases, cancer, diabetes, growth hormone deficiencies, hematological diseases, kidney failure, rheumatoid arthritis and others. For the manufacturing of biosimilars, manufacturers have to develop environments that are ideal for the living cells, which remain sensitive to environmental conditions. Moreover, they need to develop distinctive process to entice the living cells for producing similar outcome to a prevalent biological treatment. The substitution of biological drugs with biosimilar drugs can save lot of money for public health care sector and patients. The regulatory authorities in developed nations are promoting biosimilar products. The global Biosimilar market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of 25.0% during 2019-2025. This report focuses on Biosimilar volume and value at global level, regional level and company level. From a global perspective, this report represents overall Biosimilar market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Allergan plc BIOCAD Biocon BioXpress Therapeutics Boehringer Ingelheim Celltrion Coherus BioSciences Dr. Reddy’s Laboratories Genor BioPharma Intas Pharmaceuticals Limited Novartis Pfizer Reliance Life Sciences Segment by Regions North America Europe China Japan Segment by Type Human Growth Hormones Monoclonal Antibodies Insulin Peptides Erythropoietin Others Segment by Application Oncology Chronic and Autoimmune Diseases Growth Hormone Deficiency Infectious Diseases Others
Table of Contents Executive Summary 1 Biosimilar Market Overview 1.1 Product Overview and Scope of Biosimilar 1.2 Biosimilar Segment by Type 1.2.1 Global Biosimilar Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Human Growth Hormones 1.2.3 Monoclonal Antibodies 1.2.4 Insulin 1.2.5 Peptides 1.2.6 Erythropoietin 1.2.7 Others 1.3 Biosimilar Segment by Application 1.3.1 Biosimilar Consumption Comparison by Application (2014-2025) 1.3.2 Oncology 1.3.3 Chronic and Autoimmune Diseases 1.3.4 Growth Hormone Deficiency 1.3.5 Infectious Diseases 1.3.6 Others 1.3 Global Biosimilar Market by Region 1.3.1 Global Biosimilar Market Size Region 1.3.2 North America Status and Prospect (2014-2025) 1.3.3 Europe Status and Prospect (2014-2025) 1.3.4 China Status and Prospect (2014-2025) 1.3.5 Japan Status and Prospect (2014-2025) 1.3.6 Southeast Asia Status and Prospect (2014-2025) 1.3.7 India Status and Prospect (2014-2025) 1.4 Global Biosimilar Market Size 1.4.1 Global Biosimilar Revenue (2014-2025) 1.4.2 Global Biosimilar Production (2014-2025) 2 Global Biosimilar Market Competition by Manufacturers 2.1 Global Biosimilar Production Market Share by Manufacturers (2014-2019) 2.2 Global Biosimilar Revenue Share by Manufacturers (2014-2019) 2.3 Global Biosimilar Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Biosimilar Production Sites, Area Served, Product Types 2.5 Biosimilar Market Competitive Situation and Trends 2.5.1 Biosimilar Market Concentration Rate 2.5.2 Biosimilar Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Biosimilar Production Market Share by Regions 3.1 Global Biosimilar Production Market Share by Regions 3.2 Global Biosimilar Revenue Market Share by Regions (2014-2019) 3.3 Global Biosimilar Production, Revenue, Price and ... | read more...